IE
KRYS icon

Israel Englander’s Krystal Biotech KRYS Stock Holding History

Israel Englander’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,000
Closed -$541K – 6118
2025
Q1 		$541K Sell
3,000
-12,200
-80% -$2.05M ﹤0.01% 4758
2024
Q4 		$2.38M Sell
15,200
-20,600
-58% -$3.65M ﹤0.01% 3482
2024
Q3 		$6.52M Buy
35,800
+27,200
+316% +$5.24M ﹤0.01% 2608
2024
Q2 		$1.58M Buy
8,600
+3,400
+65% +$571K ﹤0.01% 3738
2024
Q1 		$925K Buy
+5,200
New +$722K ﹤0.01% 4361
2023
Q4 		– Sell
-10,000
Closed -$1.16M – 6320
2023
Q3 		$1.16M Buy
10,000
+4,900
+96% +$598K ﹤0.01% 4075
2023
Q2 		$599K Buy
+5,100
New +$521K ﹤0.01% 4411
2022
Q4 		– Sell
-10,000
Closed -$697K – 6814
2022
Q3 		$697K Sell
10,000
-41,000
-80% -$2.96M ﹤0.01% 4661
2022
Q2 		$3.35M Buy
51,000
+41,000
+410% +$2.55M ﹤0.01% 3197
2022
Q1 		$665K Buy
+10,000
New +$624K ﹤0.01% 4892
2021
Q3 		– Sell
-3,200
Closed -$218K – 7041
2021
Q2 		$218K Sell
3,200
-25,400
-89% -$1.77M ﹤0.01% 5963
2021
Q1 		$2.2M Buy
28,600
+15,800
+123% +$1.15M ﹤0.01% 3439
2020
Q4 		$768K Buy
12,800
+2,800
+28% +$140K ﹤0.01% 3901
2020
Q3 		$431 Buy
+10,000
New +$434K ﹤0.01% 3654

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Israel Englander's KRYS Position: Q2 2026 in Review

Israel Englander sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 4,119 shares — an estimated $1.06M sold.

Israel Englander first reported a position in KRYS in Q4 2017 and held it in 22 quarters. The position peaked at $26.3M in Q3 2025. 420 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Israel Englander reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 4,119 Krystal Biotech shares in Q2 2026, an estimated $1.06M.
  • Israel Englander first reported a position in Krystal Biotech in Q4 2017 and held it in 22 quarters.
  • Israel Englander's Krystal Biotech position peaked at $26.3M in Q3 2025.
  • 420 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.